NovoCure Statistics
NASDAQ: NVCRHealth CareMedical/Dental InstrumentsUSD
14.22-0.44 (-3.00%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NovoCure by the numbers
NovoCure has a market capitalization of $1.66 billion based on 116.45M shares outstanding. With trailing EPS of $-1.30, NovoCure is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.0% below its 50-day average and 3.6% below its 200-day average.
Average daily trading volume is 1.42M shares, or about $20.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NVCR valuation vs. peer median
| Metric | NVCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.66B | $1.57B | +6% |
| Avg. volume | 1.42M | 684.58K | +108% |
Peer median across 8 companies: ATEC, XRAY, KMTS, INSP, DRTS, IRMD, UFPT, TNDM.
Valuation
- Market cap
- $1.66B
- EPS (TTM)
- $-1.30
- Shares outstanding
- 116.45M
Price and trading
- Previous close
- 14.66
- Open
- 14.59
- Day range
- 13.82 – 14.59
- 52-week range
- 9.82 – 21.45
- 52-week change
- -0.91%
- Beta
- —
- Volume
- 2.36M
- Average volume
- 1.42M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 1.66B
- Forward Pe
- -17.42
- Eps
- -1.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 21.45
- Week52 Low
- 9.82
- Avg Volume
- 1.42M
- Shares Outstanding
- 116.45M
- Ma50
- 16.53
- Ma200
- 14.75
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -33.71%
- Pct From52w Low
- 44.81%